Navigation Links
GenoSpace Founder and CEO Receives "Champions of Change" Award from White House
Date:6/20/2013

CAMBRIDGE, Mass., June 20, 2013 /PRNewswire/ -- The White House today recognized John Quackenbush, PhD, founder and Chief Executive Officer of GenoSpace, LLC, as an Open Science "Champion of Change". The program recognizes outstanding individuals, organizations and research projects promoting and using open scientific data and publications to accelerate progress and improve our world. GenoSpace builds information systems capable of storing and integrating genomic information and health data for clinical care and advanced research.  Kathy Giusti, founder and Chief Executive Officer of the Multiple Myeloma Research Foundation (MMRF), was also honored as an Open Science "Champion of Change".

(Logo: http://photos.prnewswire.com/prnh/20130620/NE35753LOGO )

In 2011, the Multiple Myeloma Research Foundation (MMRF) launched the $40 million CoMMpass study, an open-science initiative that unites competitors from the pharmaceutical and biotech industries, academic institutions, and community cancer centers. The MMRF CoMMpass study will follow 1,000 patients for five years, monitoring their response to treatment and sequencing their cancer genomes to understand how they evolve under the selective pressure of drugs with which they are being treated. CoMMpass will provide unprecedented data that will be freely shared without restriction with anyone interested in using it to search for a cure.

In 2012, the MMRF turned to GenoSpace to solve the problem of making the data emerging from CoMMpass available, accessible, and useful to research community. GenoSpace for Research™, which enables the MMRF Researcher Gateway, is a revolutionary software system that integrates complex data and provides collaborating scientists with advanced analytical and visualization tools that drive discovery. The MMRF Researcher Gateway is currently open to the pharmaceutical sponsors of CoMMpass, and will be made available to the public in September of this year.

"We are very proud to have partnered with the MMRF and to be honored with them by the White House," said Quackenbush. "This award recognizes the groundbreaking work the team at GenoSpace has done in creating tools to support the next generation of genomic research and personalized medicine."

About GenoSpace
At GenoSpace, we are Digital Architects of Genomic Medicine™. GenoSpace is a Cambridge, Massachusetts-based company that has developed robust software systems for securely storing vast amounts of genomic and health data, and providing it in formats specific to its diverse user communities. GenoSpace for Clinical Care facilitates clinically actionable interpretation and report generation for precision medicine. GenoSpace for Research provides dynamic analysis, visualization and collaboration tools. GenoSpace for Patient Communities enables patient-centric exploration and advancement of personalized medicine. Please visit www.GenoSpace.com for more information.

GenoSpace Contact:
John Quackenbush
GenoSpace, LLC
700 Massachusetts Ave
Cambridge MA 02139
Phone: 617-520-4182
pr@genospace.com


'/>"/>
SOURCE GenoSpace, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GenoSpace Expands Its Management Team by Appointing Daniel Meyer as Chief Financial Officer
2. GenoSpace Announces the Launch of a Cloud-Based "Information Ecosystem" for Advancing 21st-Century Personalized Medicine
3. Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013
4. Future of Pre- and Probiotics to be Discussed by Kibow Biotech Founder During SupplySide MarketPlace 2013 Global Expo & Conference
5. TREVENTIS Corporation Scientific Founder, Donald Weaver, MD, Named Sobey Chair in Alzheimers Disease Research, His Third Endowed Chair
6. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
7. Radiotherapy Clinics of Georgias Founder Returns Home to Celebrate Cancer Survivors and Receive Lifetime Achievement Award
8. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
9. Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval
10. AMRI Burlington Receives DEA Approval to Handle Controlled Substances
11. zuChem Receives Two Polyol Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Andrew ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division ... tuned and optimized exclusively for Okuma CNC machining centers at The International Manufacturing ... collaboration among several companies with expertise in toolholding, cutting tools, machining dynamics and ...
(Date:6/23/2016)... 2016 ReportsnReports.com adds 2016 ... its pharmaceuticals section with historic and forecast data ... more. Complete report on the Cell ... 15 companies and supported with 261 tables and ... . The Global Cell Culture Media ...
Breaking Biology Technology:
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):